Software startup Truveris completed $25 million in Series D financing. The round was led by McKesson Ventures, with participation from Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, and New Atlantic Ventures.
Truveris’ mission is to bring transparency to the prescription drug ecosystem through data-driven innovations. Its platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – data and insights to manage rising costs and market access challenges efficiently.
According to the company, this strategic investment enables Truveris rapidly to expand the availability of its platform to help more organizations reduce costs and improve access to medication.